Copyright Reports & Markets. All rights reserved.

Global Hepatitis B Vaccines Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Hepatitis B Vaccines Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Yeast Derived
    • 1.3.3 CHO Derived
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Hepatitis B Vaccines Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Children
    • 1.4.3 Adult
  • 1.5 Global Hepatitis B Vaccines Market Size & Forecast
    • 1.5.1 Global Hepatitis B Vaccines Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Hepatitis B Vaccines Sales Quantity (2019-2030)
    • 1.5.3 Global Hepatitis B Vaccines Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 GSK
    • 2.1.1 GSK Details
    • 2.1.2 GSK Major Business
    • 2.1.3 GSK Hepatitis B Vaccines Product and Services
    • 2.1.4 GSK Hepatitis B Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 GSK Recent Developments/Updates
  • 2.2 NCPC
    • 2.2.1 NCPC Details
    • 2.2.2 NCPC Major Business
    • 2.2.3 NCPC Hepatitis B Vaccines Product and Services
    • 2.2.4 NCPC Hepatitis B Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 NCPC Recent Developments/Updates
  • 2.3 Merck
    • 2.3.1 Merck Details
    • 2.3.2 Merck Major Business
    • 2.3.3 Merck Hepatitis B Vaccines Product and Services
    • 2.3.4 Merck Hepatitis B Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Merck Recent Developments/Updates
  • 2.4 Bio Kangtai
    • 2.4.1 Bio Kangtai Details
    • 2.4.2 Bio Kangtai Major Business
    • 2.4.3 Bio Kangtai Hepatitis B Vaccines Product and Services
    • 2.4.4 Bio Kangtai Hepatitis B Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Bio Kangtai Recent Developments/Updates
  • 2.5 Dynavax
    • 2.5.1 Dynavax Details
    • 2.5.2 Dynavax Major Business
    • 2.5.3 Dynavax Hepatitis B Vaccines Product and Services
    • 2.5.4 Dynavax Hepatitis B Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Dynavax Recent Developments/Updates
  • 2.6 AIM Vaccine
    • 2.6.1 AIM Vaccine Details
    • 2.6.2 AIM Vaccine Major Business
    • 2.6.3 AIM Vaccine Hepatitis B Vaccines Product and Services
    • 2.6.4 AIM Vaccine Hepatitis B Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 AIM Vaccine Recent Developments/Updates
  • 2.7 KM Biologics
    • 2.7.1 KM Biologics Details
    • 2.7.2 KM Biologics Major Business
    • 2.7.3 KM Biologics Hepatitis B Vaccines Product and Services
    • 2.7.4 KM Biologics Hepatitis B Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 KM Biologics Recent Developments/Updates
  • 2.8 LG Life Sciences
    • 2.8.1 LG Life Sciences Details
    • 2.8.2 LG Life Sciences Major Business
    • 2.8.3 LG Life Sciences Hepatitis B Vaccines Product and Services
    • 2.8.4 LG Life Sciences Hepatitis B Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 LG Life Sciences Recent Developments/Updates
  • 2.9 Serum Institute
    • 2.9.1 Serum Institute Details
    • 2.9.2 Serum Institute Major Business
    • 2.9.3 Serum Institute Hepatitis B Vaccines Product and Services
    • 2.9.4 Serum Institute Hepatitis B Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Serum Institute Recent Developments/Updates

3 Competitive Environment: Hepatitis B Vaccines by Manufacturer

  • 3.1 Global Hepatitis B Vaccines Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Hepatitis B Vaccines Revenue by Manufacturer (2019-2024)
  • 3.3 Global Hepatitis B Vaccines Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Hepatitis B Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Hepatitis B Vaccines Manufacturer Market Share in 2023
    • 3.4.3 Top 6 Hepatitis B Vaccines Manufacturer Market Share in 2023
  • 3.5 Hepatitis B Vaccines Market: Overall Company Footprint Analysis
    • 3.5.1 Hepatitis B Vaccines Market: Region Footprint
    • 3.5.2 Hepatitis B Vaccines Market: Company Product Type Footprint
    • 3.5.3 Hepatitis B Vaccines Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Hepatitis B Vaccines Market Size by Region
    • 4.1.1 Global Hepatitis B Vaccines Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Hepatitis B Vaccines Consumption Value by Region (2019-2030)
    • 4.1.3 Global Hepatitis B Vaccines Average Price by Region (2019-2030)
  • 4.2 North America Hepatitis B Vaccines Consumption Value (2019-2030)
  • 4.3 Europe Hepatitis B Vaccines Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Hepatitis B Vaccines Consumption Value (2019-2030)
  • 4.5 South America Hepatitis B Vaccines Consumption Value (2019-2030)
  • 4.6 Middle East & Africa Hepatitis B Vaccines Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Hepatitis B Vaccines Sales Quantity by Type (2019-2030)
  • 5.2 Global Hepatitis B Vaccines Consumption Value by Type (2019-2030)
  • 5.3 Global Hepatitis B Vaccines Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Hepatitis B Vaccines Sales Quantity by Application (2019-2030)
  • 6.2 Global Hepatitis B Vaccines Consumption Value by Application (2019-2030)
  • 6.3 Global Hepatitis B Vaccines Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Hepatitis B Vaccines Sales Quantity by Type (2019-2030)
  • 7.2 North America Hepatitis B Vaccines Sales Quantity by Application (2019-2030)
  • 7.3 North America Hepatitis B Vaccines Market Size by Country
    • 7.3.1 North America Hepatitis B Vaccines Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Hepatitis B Vaccines Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Hepatitis B Vaccines Sales Quantity by Type (2019-2030)
  • 8.2 Europe Hepatitis B Vaccines Sales Quantity by Application (2019-2030)
  • 8.3 Europe Hepatitis B Vaccines Market Size by Country
    • 8.3.1 Europe Hepatitis B Vaccines Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Hepatitis B Vaccines Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Hepatitis B Vaccines Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Hepatitis B Vaccines Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Hepatitis B Vaccines Market Size by Region
    • 9.3.1 Asia-Pacific Hepatitis B Vaccines Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Hepatitis B Vaccines Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Hepatitis B Vaccines Sales Quantity by Type (2019-2030)
  • 10.2 South America Hepatitis B Vaccines Sales Quantity by Application (2019-2030)
  • 10.3 South America Hepatitis B Vaccines Market Size by Country
    • 10.3.1 South America Hepatitis B Vaccines Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Hepatitis B Vaccines Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Hepatitis B Vaccines Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Hepatitis B Vaccines Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Hepatitis B Vaccines Market Size by Country
    • 11.3.1 Middle East & Africa Hepatitis B Vaccines Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Hepatitis B Vaccines Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Hepatitis B Vaccines Market Drivers
  • 12.2 Hepatitis B Vaccines Market Restraints
  • 12.3 Hepatitis B Vaccines Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Hepatitis B Vaccines and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Hepatitis B Vaccines
  • 13.3 Hepatitis B Vaccines Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Hepatitis B Vaccines Typical Distributors
  • 14.3 Hepatitis B Vaccines Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Hepatitis B vaccine is a vaccine that prevents hepatitis B. The first dose is recommended within 24 hours of birth with either two or three more doses given after that. This includes those with poor immune function such as from HIV/AIDS and those born premature. It is also recommended that health-care workers be vaccinated. In healthy people routine immunization results in more than 95% of people being protected.
    According to our (Global Info Research) latest study, the global Hepatitis B Vaccines market size was valued at US$ 1306 million in 2023 and is forecast to a readjusted size of USD 2025 million by 2030 with a CAGR of 6.3% during review period.
    Global key players of Hepatitis B Vaccines include GSK, Dynavax, NCPC, etc. The top three players hold a share about 65%. North America is the largest market, and has a share about 45%, followed by Asia-Pacific and Europe with share 31% and 17%, separately. In terms of product type, Yeast Derived is the largest segment, occupied for a share of 85%. In terms of application, Adult is the largest field with a share about 64 percent.
    This report is a detailed and comprehensive analysis for global Hepatitis B Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Hepatitis B Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (US$/Dose), 2019-2030
    Global Hepatitis B Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (US$/Dose), 2019-2030
    Global Hepatitis B Vaccines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (US$/Dose), 2019-2030
    Global Hepatitis B Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (M Doses), and ASP (US$/Dose), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Hepatitis B Vaccines
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Hepatitis B Vaccines market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, NCPC, Merck, Bio Kangtai, Dynavax, AIM Vaccine, KM Biologics, LG Life Sciences, Serum Institute, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Hepatitis B Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Yeast Derived
    CHO Derived
    Market segment by Application
    Children
    Adult
    Major players covered
    GSK
    NCPC
    Merck
    Bio Kangtai
    Dynavax
    AIM Vaccine
    KM Biologics
    LG Life Sciences
    Serum Institute
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Hepatitis B Vaccines product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Hepatitis B Vaccines, with price, sales quantity, revenue, and global market share of Hepatitis B Vaccines from 2019 to 2024.
    Chapter 3, the Hepatitis B Vaccines competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Hepatitis B Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Hepatitis B Vaccines market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Hepatitis B Vaccines.
    Chapter 14 and 15, to describe Hepatitis B Vaccines sales channel, distributors, customers, research findings and conclusion.

    Buy now